Edwards Lifesciences Corporation (BIT:1EW)

Edwards Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	3,045	1,132	769	862.8	1,183
Short-Term Investments	-	930.7	500.5	446.3	604	219.4
Cash & Short-Term Investments	3,899	3,976	1,633	1,215	1,467	1,403
Cash Growth	95.92%	143.50%	34.35%	-17.15%	4.58%	-7.54%
Accounts Receivable	-	609.1	771.5	643	582.2	514.6
Other Receivables	-	118.3	56.6	56.1	82.7	88.2
Receivables	-	727.4	828.1	699.1	664.9	602.8
Inventory	-	1,087	903.5	875.5	726.7	802.3
Prepaid Expenses	-	121	128.8	110	85.2	75.1
Restricted Cash	-	3.2	3.3	0.5	1.5	16.6
Other Current Assets	-	371.2	539.2	195.4	235.6	191.6
Total Current Assets	-	6,285	4,036	3,096	3,181	3,091
Property, Plant & Equipment	-	1,784	1,675	1,725	1,639	1,489
Long-Term Investments	-	307.9	583.9	1,239	1,834	801.6
Goodwill	-	1,777	1,145	1,164	1,168	1,173
Other Intangible Assets	-	1,177	399.4	285.2	323.6	331.4
Long-Term Deferred Tax Assets	-	992.1	749.4	484	246.7	230.9
Other Long-Term Assets	-	603.1	619.2	299.1	110.8	119.6
Total Assets	-	13,055	9,363	8,293	8,503	7,237
Accounts Payable	-	197.4	186.6	201.9	204.5	196.5
Accrued Expenses	-	790.4	667.2	593.1	643.4	516
Current Portion of Leases	-	23.4	22.9	25.5	25.5	27.2
Current Income Taxes Payable	-	286.6	52.7	50.6	30.6	18.6
Current Unearned Revenue	-	53.7	-	-	-	-
Other Current Liabilities	-	153.7	266	151.3	128.3	135.6
Total Current Liabilities	-	1,505	1,195	1,022	1,032	893.9
Long-Term Debt	-	597.7	597	596.3	595.7	595
Long-Term Leases	-	78.9	65.2	69.5	69.1	72.7
Other Long-Term Liabilities	-	778.5	750	774.1	928.6	1,048
Total Liabilities	-	2,992	2,644	2,486	2,667	2,663
Common Stock	-	654.8	650.5	646.3	642	636.4
Additional Paid-In Capital	-	2,613	2,274	1,969	1,700	1,438
Retained Earnings	-	13,167	8,992	7,590	6,068	4,565
Treasury Stock	-	-6,192	-5,025	-4,144	-2,417	-1,904
Comprehensive Income & Other	-	-244.5	-242.8	-254.9	-157.7	-161.1
Total Common Equity	10,129	9,998	6,650	5,807	5,836	4,574
Minority Interest	-	64.5	69.4	-	-	-
Shareholders' Equity	10,192	10,063	6,719	5,807	5,836	4,574
Total Liabilities & Equity	-	13,055	9,363	8,293	8,503	7,237
Total Debt	699.4	700	685.1	691.3	690.3	694.9
Net Cash (Debt)	3,205	3,281	947.7	524	776.5	707.7
Net Cash Growth	147.12%	246.25%	80.86%	-32.52%	9.72%	-15.56%
Net Cash Per Share	5.42	5.48	1.56	0.84	1.23	1.12
Filing Date Shares Outstanding	587	587.9	601.3	608.31	623.21	624.52
Total Common Shares Outstanding	587	588.6	601.1	608.3	624.1	624.3
Working Capital	-	4,780	2,840	2,073	2,148	2,197
Book Value Per Share	17.28	16.99	11.06	9.55	9.35	7.33
Tangible Book Value	7,175	7,045	5,106	4,357	4,344	3,070
Tangible Book Value Per Share	12.24	11.97	8.49	7.16	6.96	4.92
Land	-	123.9	112.4	116.3	116.5	97.6
Buildings	-	1,340	1,189	1,189	1,010	881.5
Machinery	-	689.4	618.6	735	652.6	607.1
Construction In Progress	-	244	292.5	255.2	333.8	313.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.